Healthcare In Court

Courts Take On Lilly GLP-1 Ads, J&J Mesothelioma Trial, More

By Gianna Ferrarin · October 27, 2026, 6:48 PM EDT

Novo Nordisk Inc. can't preliminarily block allegedly deceptive ads by Eli Lilly & Co. comparing the rivals' GLP-1 medicines, a New Jersey federal court decided....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Case Number

2:16-md-02724

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 05, 2016

Case Title

Connecticut et al v. Aurobindo Pharma USA, Inc. et al

Case Number

3:16-cv-02056

Court

Connecticut

Nature of Suit

410 Anti-Trust

Date Filed

December 15, 2016

Case Title

Connecticut et al v. Teva Pharmaceuticals USA, Inc.

Case Number

3:19-cv-00710

Court

Connecticut

Nature of Suit

410 Anti-Trust

Date Filed

May 10, 2019

Case Title

Connecticut et al v. Sandoz, Inc. et al

Case Number

3:20-cv-00802

Court

Connecticut

Nature of Suit

410 Anti-Trust

Date Filed

June 10, 2020

Case Title

NOVO NORDISK INC. v. ELI LILLY AND COMPANY et al

Case Number

3:26-cv-09027

Court

New Jersey

Nature of Suit

Commerce ICC Rates, Etc.

Date Filed

July 21, 2026